Quadrant Capital Group’s Shattuck Labs STTK Stock Holding History

Quadrant Capital Group’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8	Closed	–	–	2641
2021 Q2	$0	Buy	+8	New	+$234	﹤0.01%	2552

Other funds holding STTK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CEI

Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Quadrant Capital Group's STTK Position: Q3 2021 in Review

Quadrant Capital Group sold out of Shattuck Labs (STTK) in Q3 2021, closing a stake of 8 shares.

Quadrant Capital Group first reported a position in STTK in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 70 funds tracked by Wall St. Rank hold STTK as of Q3 2021.

Quadrant Capital Group reported no remaining Shattuck Labs position as of Q3 2021 after selling out during the quarter.
Quadrant Capital Group sold 8 Shattuck Labs shares in Q3 2021.
Quadrant Capital Group first reported a position in Shattuck Labs in Q2 2021 and held it in 1 quarter.
Quadrant Capital Group's Shattuck Labs position peaked at $0 in Q2 2021.
70 funds tracked by Wall St. Rank held Shattuck Labs as of Q3 2021.

Based on Quadrant Capital Group's 13F filing for Q3 2021, filed 12 Nov 2021.